There are big things afoot at Endo Health Solutions (NSDQ:ENDP), which announced plans to pick up specialty pharmaceuticals maker Paladin Labs in a deal valued at $1.6 billion.
Endo Health
First bellwether date set for Boston Scientific in pelvic mesh lawsuits
The 1st bellwether trial in the multi-district litigation filed over Boston Scientific‘s (NYSE:BSX) pelvic mesh products is slated for early next year, a federal judge ordered this week.
Pelvic mesh makers look to settle lawsuits
Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they’re facing in the U.S., anonymous sources told Bloomberg.
Endo Health taps new CFO from Becton Dickinson | Personnel Moves
Endo Health’s profits surge despite Q2 sales dip
Endo Health Solutions (NSDQ:ENDP) managed to boost its profits by 270% during the 2nd quarter, despite declining sales and a $60 million set-aside for lawsuits filed over the pelvic mesh business it acquired along with American Medical Systems for nearly $3 billion in 2011.
Endo Health’s American Medical Systems to settle mesh lawsuits for $55M
Endo Health Solutions (NSDQ:ENDP) subsidiary American Medical Systems said it’s agreed to pay $54 million to settle personal injury lawsuits filed over its pelvic mesh products.
Ivantis reels in $27M Series B round | Wall Street Beat
Ivantis said it raised a $27 million Series B round led by Ascension Health Ventures aimed at funding a quartet of clinical trials for its Hydrus Microstent glaucoma treatment.
The Irvine, Calif.-based medical device company said the device, an eyelash-sized stent, is designed to reduce eye pressure.
Juror selection begins for Johnson & Johnson transvaginal mesh lawsuits | MassDevice.com On Call
MASSDEVICE ON CALL — A bellwether trial against Johnson & Johnson (NYSE:JNJ) began this month with lawyers beginning to select jurors to hear a lawsuit accusing the healthcare giant of liability patient injuries allegedly caused by the company’s transvaginal mesh implants.
Legal fights over recalled hips and transvaginal mesh begin this year | MassDevice.com On Call
MASSDEVICE ON CALL — This year promises to be a big one for medical device legal battles, as bellwether trials for several high-profile device disputes are slated for later in 2013.
FDA probes JNJ, Bard and others on transvaginal mesh risks
Mesh lawsuits pile up for C.R. Bard
Dozens of patients with lawsuits against C.R. Bard Inc. (NYSE:BCR) asked to join a multi-district federal case against the company for allegedly selling defective and dangerous products – its Avaulta transvaginal mesh.
In one of the most recent suits, Lois Houghton wants a jury to decide whether Bard was negligent in designing the product and whether it failed to warn patients and doctors of potential risks.